The largest database of trusted experimental protocols

6 protocols using thymidine

1

Synchronizing HeLa Cell Cycle Stages

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were grown in Dulbecco’s Modified Eagle’s Medium (Lonza), supplemented with 10% fetal bovine serum (Sigma), 1% penicillin/streptomycin (Sigma) and 1%w/v L-glutamine at 37 °C. For interphase arrest, cells were first treated with 2 mM thymidine (Santa Cruz, 296542 A), released for 8 hours and then treated again with 2 mM thymidine for 17 hours. For mitosis synchronization, cells were treated with 10 µM STC (Sigma, 164739-5G164739) for 12 hours. To induce monopolar cytokinesis, cells were subsequently treated with 30 µM Purvalanol A (Tocris Bioscience, 1580) for 15 minutes and then washed immediately and extensively with PBS.
To induce synchronization in bipolar cytokinesis, following double thymidine blocking, the cells were released for 7 hours, then incubated with 0 ng/ml, 10 ng/ml and 25 ng/ml of Nocodazole (Calbiochem, 487928) for 4 or 5 hours. Next, cells were extensively washed with PBS. Mitotic cells were collected by gentle shaking and incubated for 50 or 60 minutes in the new plate.
+ Open protocol
+ Expand
2

Cell Synchronization Protocols for Biochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were synchronised at prometaphase by treatment with 5 µM S-trityl-L-cysteine (STLC; 164739, Sigma) for 20 h. For biochemistry, cells were synchronized using 2 mM thymidine (#296542A, Santa Cruz Biotechnology) for 16 h and released into fresh complete medium for 8 h, followed by either 16 h of 2 mM thymidine (interphase block) or 20 h of 5 µM STLC (prometaphase block) incubation.
+ Open protocol
+ Expand
3

Cell Cycle Synchronization and Arrest Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa S3 cells (ATCC CCL-2.2) were maintained in DMEM high glucose supplemented with 10% fetal bovine serum (Gibco) and 1% penicillin–streptomycin (Lonza) at 37°C in a humidified atmosphere containing 5% CO2. The arrest of cell cycle progression during interphase was achieved by double thymidine block. Briefly, 2 mM thymidine (296542; Santa Cruz Biotechnology) was added to the cell culture medium, and the cells were incubated for 16 h at 37°C. Then, the cells were incubated in complete medium without thymidine for 8 h. After the second thymidine block of the cells for 16 h, most of the cells were arrested in the G1 phase of interphase. For mitotic arrest, the cells were incubated in complete medium without thymidine for 8 h after the second thymidine block. Then, 10 ng/ml of nocodazole (487928; Calbiochem) was added to the cell culture medium and the cells were incubated for 5 h. At the end of the incubation with nocodazole, the cells were arrested in prometaphase. For cytokinesis arrest, the cells were incubated in complete medium for 1 h after nocodazole treatment. To induce monopolar cytokinesis, after the second thymidine block, the cells were incubated in complete medium containing 10 μM S-trityl-L-cysteine (STC) (164739; Sigma-Aldrich) for 16 h. Then, 100 μm purvalanol-A (1580; Tocris Bioscience) was added to the cell culture medium and the cells were incubated for 15 min.
+ Open protocol
+ Expand
4

Cell Cycle Regulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following chemicals were used: RO3306 (Axon MedChem), Okadaic Acid sodium salt (A.G. Scientifix), Thymidine and 2’-Deoxycytidine hydrate (Santa Cruz Biotechnology). The following antibodies were used; BUB1B (BubR1) (#4116), Cyclin B1 (#12231), Phospho-(Ser) CDK Substrate (#2324), pCdc2-Tyr15 (CDK1-Y15) (#9111), Plk1 (#4535), Aurora B (#3094) and Lamin A/C (#4777) (Cell Signaling Technologies), Securin (ab3306) (Abcam), Cyclin A (sc-596), Cdc2 (CDK1) (sc-137034), Mad2 (sc-47747), Cdc25C (sc-327) (Santa Cruz Biotechnology), centrin (#04–1624) (Millipore) and β-actin (A5441) (Sigma-Aldrich). Anti-Greatwall was obtained as previously described (Vigneron et al., 2009), and monoclonal β-Tubulin hybridoma antibody was a generous donation from Dr Natalie Morin (CRBM, France).
+ Open protocol
+ Expand
5

Cell Cycle Synchronization Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synchronization of cells was accomplished by treating cells with reversible cell cycle arresting agents, followed by two washes with warmed 1x and release into fresh media. Double thymidine blocks were used to arrest cells at early S phase, by treating cells with 2 mM thymidine (Sigma) for 18 h followed by release for 9 h and treatment with 2 mM thymidine for an additional 17 h before release into S phase. To arrest cells in M-phase, cells were first arrested at early S by a 24 h thymidine block as above followed by treatment with 100 ng/ml nocodazole (Sigma) for 12 h. To release from nocodazole cells were harvested by mitotic shake off, washed with 1 × PBS and reseeded in fresh media. Synchronization of cells at G2/M was accomplished by first blocking cells in early S phase by 24 h treatment with 2 mM thymidine followed by 12 h treatment with 9 μM RO-3306 (Santa Cruz), a potent CDK1 inhibitor. Cells were then released into mitosis by two washes with 1 × PBS and supplemented with fresh media.
+ Open protocol
+ Expand
6

Cell Culture and Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were propagated in Dulbecco’s modified Eagle’s medium supplemented with 10% (v/v) calf serum (for HeLa) or fetal bovine serum (for H1299) and 50 U/ml of penicillin streptomycin (Thermo Fisher Scientific).
Unless stated otherwise, cells were treated with the following reagents at the indicated final concentration: blasticidin (Thermo Fisher Scientific; 3.75 μg/ml for transient selection; 2.5 μg/ml for stable selection), CHK1i (AZD7762) (Selleck Chemicals; 20 nM), CHX (Sigma-Aldrich; 10 μg/ml), Dox (Sigma-Aldrich; 2 μg/ml), hygromycin B (Thermo Fisher Scientific; 0.25 mg/ml), IAA (Sigma-Aldrich; 50 μg/ml), nocodazole (NOC) (Sigma-Aldrich; 100 ng/ml), puromycin (Sigma-Aldrich; 0.75 μg/ml for transient selection; 0.3 μg/ml for stable selection), RO3306 (Santa Cruz Biotechnology; 10 μM), and thymidine (Santa Cruz Biotechnology; 2 mM). Cells were transfected with plasmids using a calcium phosphate precipitation method (63 ). Transfection of siRNA (10 nM) was carried out using Lipofectamine RNAiMAX (Thermo Fisher Scientific) according to manufacturer instructions. Unless stated otherwise, transfected cells were cultured for 24 h before harvested for further analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!